Beam Therapeutics receives Harvard license – Harvard Gazette
Harvard Gazette |
Beam Therapeutics receives Harvard license
Harvard Gazette Genome editing technologies using the CRISPR platform in combination with enzymes like Cas9 and Cpf1 have shown great promise for adjusting genes through insertions or deletions of multiple nucleotides, but have had more difficulty correcting single … |
